DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

NCT01423812 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: Twice-daily combination Darunavir and ritonavir
DRUG: Once-daily combination Darunavir and ritonavir

Sponsor

Ruth M. Rothstein CORE Center

Collaborators

[object Object]